Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Taira Ninomaru
Observed names:
Ninomaru, Taira,
T. Ninomaru
Institution:
Hyogo Prefectural Harima-Himeji General Medical Center
Observed institutions:
Kobe Medical Center,
Akashi Medical Center,
AKO City Hospital,
Hyogo Prefectural Harima-Himeji General Medical Center
ORCID:
0000-0001-5681-1855
Observed ORCID:
0000-0001-5681-1855
OpenAlex ID:
A5057637154
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
2022
·
Hiroshi Mayahara
, Kazuyuki Uehara
, et al.
·
Radiation Oncology
·
37
Lazarus Response to Tepotinib for Leptomeningeal Metastases in a Patient With MET Exon 14 Skipping Mutation–Positive Lung Adenocarcinoma: Case Report
2021
·
Taira Ninomaru
, Hideaki Okada
, et al.
·
JTO Clinical and Research Reports
·
14
Higher osimertinib introduction rate achieved by multiple repeated rebiopsy after acquired resistance to first/second generation EGFR‐TKIs
2021
·
Taira Ninomaru
, Akito Hata
, et al.
·
Thoracic Cancer
·
12
PDF
Left ventricular outflow tract obstruction caused by massive mitral annular calcification in a patient with hypertensive heart disease
2015
·
Naofumi Yoshida
, Tatsuya Miyoshi
, et al.
·
Journal of Cardiology Cases
·
10
PDF
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study
2025
·
Akito Hata
, Taira Ninomaru
, et al.
·
The Lancet Oncology
·
8
Continuous immunotherapy beyond progression in clinical practice for small cell lung cancer
2024
·
Ken Yamamoto
, Taira Ninomaru
, et al.
·
Thoracic Cancer
·
8
PDF
Heterogeneity or transformation? A whack‐a‐mole case of EGFR ‐mutant lung adenocarcinoma and small cell carcinoma: A case report
2022
·
Taira Ninomaru
, Akito Hata
, et al.
·
Thoracic Cancer
·
6
PDF
Endobronchial metastases 20 years after prostate cancer excision
2019
·
Yukihisa Hatakeyama
, Sho Yoshimura
, et al.
·
Respiratory Medicine Case Reports
·
5
PDF
Evaluation of platelet reactivity using P2Y12 reaction units in acute coronary syndrome with essential thrombocythemia: A case report
2015
·
Naofumi Yoshida
, Noritoshi Hiranuma
, et al.
·
Journal of Cardiology Cases
·
5
PDF
Radiation therapy (RT)-free pembrolizumab plus chemotherapy (P+C) for PD-L1 TPS ≥50% locally advanced non-small cell lung cancer (LA-NSCLC): Primary analysis from multicenter single arm phase II study (Evolution trial; WJOG11819L).
2024
·
Akito Hata
, Taira Ninomaru
, et al.
·
Journal of Clinical Oncology
·
2
EP13.07-02 Is Concept of Continuous Immunotherapy Beyond Progression Effective in Small Cell Lung Cancer?
2023
·
K. Yamamoto
, K. Hirano
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Higher osimertinib introduction rate achieved by multiple repeated re-biopsy after acquired resistance to first/second generation EGFR-TKIs
2019
·
T. Ninomaru
, A. Hata
, et al.
·
Annals of Oncology
·
1
Durable Response to Pembrolizumab With Chemotherapy in EGFR-Mutated Squamous Cell Lung Cancer: A Case Report
2025
·
Taira Ninomaru
, Sho Yoshimura
, et al.
·
Cureus
PDF
Radiation therapy (RT)-free pembrolizumab plus chemotherapy (P+C) for PD-L1 TPS ≥50% locally advanced non-small cell lung cancer (LA-NSCLC): An early report analyzing depth of response from multicenter single arm phase II study (Evolution trial: WJOG11819L).
2023
·
Akito Hata
, Taira Ninomaru
, et al.
·
Journal of Clinical Oncology
[How to Preserve QOL of Patients with Small Cell Lung Cancer-Cutting‒Edge Treatment of Brain and Bone Metastases].
2021
·
Taira Ninomaru
, Akito Hata
·
PubMed
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care
2019
·
Yoko Kida
, Akihiko Ikeda
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
18
Citation count:
109
H-index:
6
I10-index:
4
Year
Topic
Type